Funds and ETFs Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 23:00:00 28/04/2024 BST 5-day change 1st Jan Change
25.08 CNY +1.09% Intraday chart for Jiangsu Nhwa Pharmaceutical Co., LTD +7.73% -7.52%

ETFs positioned on Jiangsu Nhwa Pharmaceutical Co., LTD

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +2.43% -
Jiangsu Nhwa Pharmaceutical Co., LTD is a China-based company principally engaged in the production and sales of pharmaceutical preparations. The Company offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The Company is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
25.08 CNY
Average target price
32.21 CNY
Spread / Average Target
+28.41%
Consensus
  1. Stock Market
  2. Equities
  3. 002262 Stock
  4. Funds and ETFs Jiangsu Nhwa Pharmaceutical Co., LTD